+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2023-2030- Product Image
Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2023-2030- Product Image
Sale

Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4858015
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Line Development Market size was estimated at USD 4.98 billion in 2022, USD 5.69 billion in 2023, and is expected to grow at a CAGR of 14.32% to reach USD 14.54 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Line Development Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Line Development Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Line Development Market, highlighting leading vendors and their innovative profiles. These include Advanced Instruments, LLC, AGC Biologics, Aragen Bioscience, Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Corning Incorporated, Cyagen Biosciences, Danaher Corporation, EuBiologics Co.,Ltd., Eurofins Scientific, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., GE HealthCare Technologies Inc., GenScript Biotech Corporation, Lonza Group AG, Merck KGaA, Novartis AG, PromoCell GmbH, Rentschler Biopharma SE, Samsung Biologics Co., Ltd., Sartorius AG, Selexis SA, Syngene International Ltd., Thermo Fisher Scientific Inc., Vista Biologicals Corporation, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Cell Line Development Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Continuous Cell Lines
    • Hybridomas
    • Primary Cell Lines
    • Recombinant Cell Lines
  • Source
    • Amphibian
    • Insect
    • Mammalian
  • Product
    • Equipment
      • Automated Systems
      • Bioreactors
      • Biosafety Cabinets
      • Cell Counters and Viability Systems
      • Centrifuges
      • Filtration Systems
      • Incubators
      • Microscopes
      • Storage Equipment
    • Media and Reagents
      • Media
        • Minimum Essential Media
        • Reduced Serum Media
        • Serum-free Media
      • Reagents
        • Buffers and Chemicals
        • Cell Dissociation Reagents
        • Cryopreservative Reagents
        • Supplements and Growth Factors
      • Serum
        • Adult Bovine Serum
        • Fetal Bovine Serum
  • Application
    • Bioproduction
      • Diagnostics
      • Recombinant Protein Therapeutics
      • Vaccine Production
    • Drug Discovery
      • Disease Modeling
      • Drug Screening and Development
      • Target Validation
    • Research
    • Tissue Engineering & Regenerative Medicine
    • Toxicity Testing
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cell Line Development Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Line Development Market?
  3. What are the technology trends and regulatory frameworks in the Cell Line Development Market?
  4. What is the market share of the leading vendors in the Cell Line Development Market?
  5. Which modes and strategic moves are suitable for entering the Cell Line Development Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Line Development Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase Demand for Monoclonal Antibodies Owing to Increase Application
5.1.1.2. Innovative Technologies Coupled with Increased Participation of Research Institutes and Government Agency
5.1.1.3. Growing Rise in Vaccine Production
5.1.2. Restraints
5.1.2.1. Limited Awareness and High Cost Associated with The Product and Applications
5.1.3. Opportunities
5.1.3.1. Increasing Risk of Communicable Epidemics Diseases
5.1.3.2. Potential in Low-income Countries
5.1.4. Challenges
5.1.4.1. Developing Authentic and Stable Cell Lines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Technology Advancement
5.10.1.1. Methotrexate Amplification Technology
5.10.1.2. Glutamine Synthatase Technology
5.10.1.3. Viral-Based Technology
6. Cell Line Development Market, by Type
6.1. Introduction
6.2. Continuous Cell Lines
6.3. Hybridomas
6.4. Primary Cell Lines
6.5. Recombinant Cell Lines
7. Cell Line Development Market, by Source
7.1. Introduction
7.2. Amphibian
7.3. Insect
7.4. Mammalian
8. Cell Line Development Market, by Product
8.1. Introduction
8.2. Equipment
8.3.1. Automated Systems
8.3.2. Bioreactors
8.3.3. Biosafety Cabinets
8.3.4. Cell Counters and Viability Systems
8.3.5. Centrifuges
8.3.6. Filtration Systems
8.3.7. Incubators
8.3.8. Microscopes
8.3.9. Storage Equipment
8.3. Media and Reagents
8.4.1. Media
8.4.2.1. Minimum Essential Media
8.4.2.2. Reduced Serum Media
8.4.2.3. Serum-free Media
8.4.2. Reagents
8.4.3.1. Buffers and Chemicals
8.4.3.2. Cell Dissociation Reagents
8.4.3.3. Cryopreservative Reagents
8.4.3.4. Supplements and Growth Factors
8.4.3. Serum
8.4.4.1. Adult Bovine Serum
8.4.4.2. Fetal Bovine Serum
9. Cell Line Development Market, by Application
9.1. Introduction
9.2. Bioproduction
9.3.1. Diagnostics
9.3.2. Recombinant Protein Therapeutics
9.3.3. Vaccine Production
9.3. Drug Discovery
9.4.1. Disease Modeling
9.4.2. Drug Screening and Development
9.4.3. Target Validation
9.4. Research
9.5. Tissue Engineering & Regenerative Medicine
9.6. Toxicity Testing
10. Americas Cell Line Development Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Line Development Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Line Development Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Advanced Instruments, LLC
14.1.2. AGC Biologics
14.1.3. Aragen Bioscience, Inc.
14.1.4. Boehringer Ingelheim International GmbH
14.1.5. Catalent, Inc.
14.1.6. Corning Incorporated
14.1.7. Cyagen Biosciences
14.1.8. Danaher Corporation
14.1.9. EuBiologics Co.,Ltd.
14.1.10. Eurofins Scientific
14.1.11. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
14.1.12. GE HealthCare Technologies Inc.
14.1.13. GenScript Biotech Corporation
14.1.14. Lonza Group AG
14.1.15. Merck KGaA
14.1.16. Novartis AG
14.1.17. PromoCell GmbH
14.1.18. Rentschler Biopharma SE
14.1.19. Samsung Biologics Co., Ltd.
14.1.20. Sartorius AG
14.1.21. Selexis SA
14.1.22. Syngene International Ltd.
14.1.23. Thermo Fisher Scientific Inc.
14.1.24. Vista Biologicals Corporation
14.1.25. WuXi AppTec
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CELL LINE DEVELOPMENT MARKET RESEARCH PROCESS
FIGURE 2. CELL LINE DEVELOPMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. CELL LINE DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CELL LINE DEVELOPMENT MARKET DYNAMICS
FIGURE 7. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
FIGURE 10. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 12. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. CELL LINE DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. CELL LINE DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. CELL LINE DEVELOPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CELL LINE DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CELL LINE DEVELOPMENT MARKET SIZE, BY CONTINUOUS CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL LINE DEVELOPMENT MARKET SIZE, BY HYBRIDOMAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL LINE DEVELOPMENT MARKET SIZE, BY PRIMARY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 11. CELL LINE DEVELOPMENT MARKET SIZE, BY AMPHIBIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL LINE DEVELOPMENT MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELL LINE DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 17. CELL LINE DEVELOPMENT MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CELL LINE DEVELOPMENT MARKET SIZE, BY CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CELL LINE DEVELOPMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CELL LINE DEVELOPMENT MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CELL LINE DEVELOPMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CELL LINE DEVELOPMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CELL LINE DEVELOPMENT MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 28. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 30. CELL LINE DEVELOPMENT MARKET SIZE, BY MINIMUM ESSENTIAL MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. CELL LINE DEVELOPMENT MARKET SIZE, BY REDUCED SERUM MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 35. CELL LINE DEVELOPMENT MARKET SIZE, BY BUFFERS AND CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. CELL LINE DEVELOPMENT MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. CELL LINE DEVELOPMENT MARKET SIZE, BY CRYOPRESERVATIVE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. CELL LINE DEVELOPMENT MARKET SIZE, BY SUPPLEMENTS AND GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 41. CELL LINE DEVELOPMENT MARKET SIZE, BY ADULT BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. CELL LINE DEVELOPMENT MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 46. CELL LINE DEVELOPMENT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEIN THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. CELL LINE DEVELOPMENT MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 51. CELL LINE DEVELOPMENT MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG SCREENING AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. CELL LINE DEVELOPMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. CELL LINE DEVELOPMENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. CELL LINE DEVELOPMENT MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. CELL LINE DEVELOPMENT MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 91. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 95. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 96. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 97. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 98. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 99. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 101. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 148. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 150. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 152. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 153. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 154. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 155. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 156. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 158. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 159. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 163. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 164. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 165. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 167. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 169. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 183. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 185. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 186. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 187. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 188. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 189. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 191. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 243. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 244. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 246. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 247. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 249. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 251. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 252. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 253. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 254. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 255. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 257. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 281. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 283. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 285. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 286. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 287. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 288. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 289. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 291. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 292. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 294. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 296. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 297. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 298. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 299. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 300. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 302. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 303. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 305. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 307. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 308. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 309. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 311. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 313. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 314. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 316. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 318. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 319. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 320. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 321. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 322. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 324. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 325. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 327. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 328. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 329. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 331. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 332. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 333. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 335. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 347. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 349. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 350. ITALY CELL LINE DEVELOPMENT MARKET

Companies Mentioned

  • Advanced Instruments, LLC
  • AGC Biologics
  • Aragen Bioscience, Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Corning Incorporated
  • Cyagen Biosciences
  • Danaher Corporation
  • EuBiologics Co.,Ltd.
  • Eurofins Scientific
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • GE HealthCare Technologies Inc.
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Merck KGaA
  • Novartis AG
  • PromoCell GmbH
  • Rentschler Biopharma SE
  • Samsung Biologics Co., Ltd.
  • Sartorius AG
  • Selexis SA
  • Syngene International Ltd.
  • Thermo Fisher Scientific Inc.
  • Vista Biologicals Corporation
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.54 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030 - Product Image

Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Cell Line Development - Global Strategic Business Report - Product Image

Cell Line Development - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cell Line Development Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cell Line Development Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 150 Pages
  • Global
From
Global Biotherapeutics Cell Line Development Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Biotherapeutics Cell Line Development Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 184 Pages
  • Global
From

About the Cell Line Development Market

The Cell Line Development market is a subset of the biotechnology industry that focuses on the development of cell lines for use in research and drug discovery. Cell lines are immortalized cell cultures that can be used to study the effects of drugs, toxins, and other compounds on cells. Cell lines are also used to produce biopharmaceuticals, such as monoclonal antibodies, vaccines, and gene therapies. Cell line development involves the selection, characterization, and optimization of cell lines for specific applications. This process includes the selection of the appropriate cell type, the optimization of culture conditions, and the characterization of the cell line for its suitability for the intended application. Companies in the Cell Line Development market include Thermo Fisher Scientific, Merck KGaA, Lonza, Sartorius AG, Corning Incorporated, and Charles River Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.